Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Thomboxane A2 and it's Receptor in Vascular Regulation in Women With Endometriosis

NCT05962034 is registered in ClinicalTrials.gov with Penn State University as lead sponsor.

NCT NCT05962034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05962034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Thomboxane A2 and it's Receptor in Vascular Regulation in Women With Endometriosis
Lead sponsor
Penn State University
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2024
Completion date
July 23, 2026
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis